These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7936652)

  • 21. Dissociation of mitogenesis and transforming activity by C-terminal truncation of the insulin-like growth factor-I receptor.
    Surmacz E; Sell C; Swantek J; Kato H; Roberts CT; LeRoith D; Baserga R
    Exp Cell Res; 1995 May; 218(1):370-80. PubMed ID: 7737373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function.
    Kuo ML; Chou YW; Chau YP; Huang TS
    Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Rgr oncogene (homologous to RalGDS) induces transformation and gene expression by activating Ras, Ral and Rho mediated pathways.
    Hernandez-Muñoz I; Malumbres M; Leonardi P; Pellicer A
    Oncogene; 2000 May; 19(23):2745-57. PubMed ID: 10851075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
    Palmby TR; Abe K; Karnoub AE; Der CJ
    Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. R-Ras C-terminal sequences are sufficient to confer R-Ras specificity to H-Ras.
    Hansen M; Rusyn EV; Hughes PE; Ginsberg MH; Cox AD; Willumsen BM
    Oncogene; 2002 Jun; 21(28):4448-61. PubMed ID: 12080475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of malignant growth potentials of v-Src-transformed human gallbladder epithelial cells by adenovirus-mediated dominant negative H-Ras.
    Tokumitsu Y; Nakano S; Ueno H; Niho Y
    J Cell Physiol; 2000 May; 183(2):221-7. PubMed ID: 10737897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases.
    Aguirre-Ghiso JA; Frankel P; Farias EF; Lu Z; Jiang H; Olsen A; Feig LA; de Kier Joffe EB; Foster DA
    Oncogene; 1999 Aug; 18(33):4718-25. PubMed ID: 10467419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guanine nucleotide exchange factors: activators of Ras superfamily proteins.
    Overbeck AF; Brtva TR; Cox AD; Graham SM; Huff SY; Khosravi-Far R; Quilliam LA; Solski PA; Der CJ
    Mol Reprod Dev; 1995 Dec; 42(4):468-76. PubMed ID: 8607978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RalA mediates v-Src, v-Ras, and v-Raf regulation of CD44 and fibronectin expression in NIH3T3 fibroblasts.
    Ladeda V; Frankel P; Feig LA; Foster DA; Bal de Kier Joffe E; Aguirre-Ghiso JA
    Biochem Biophys Res Commun; 2001 May; 283(4):854-61. PubMed ID: 11350063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and characterization of R-ras3: a novel member of the RAS gene family with a non-ubiquitous pattern of tissue distribution.
    Kimmelman A; Tolkacheva T; Lorenzi MV; Osada M; Chan AM
    Oncogene; 1997 Nov; 15(22):2675-85. PubMed ID: 9400994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein kinase Cepsilon is oncogenic in colon epithelial cells by interaction with the ras signal transduction pathway.
    Perletti GP; Concari P; Brusaferri S; Marras E; Piccinini F; Tashjian AH
    Oncogene; 1998 Jun; 16(25):3345-8. PubMed ID: 9681835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transformation by Raf and other oncogenes renders cells differentially sensitive to growth inhibition by a dominant negative c-jun mutant.
    Rapp UR; Troppmair J; Beck T; Birrer MJ
    Oncogene; 1994 Dec; 9(12):3493-8. PubMed ID: 7970709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav.
    Crespo P; Bustelo XR; Aaronson DS; Coso OA; Lopez-Barahona M; Barbacid M; Gutkind JS
    Oncogene; 1996 Aug; 13(3):455-60. PubMed ID: 8760286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance of NIH3T3 cells to v-fes transformation induced by a dominant negative H-ras mutant.
    Ogiso Y; Yokoyama T; Watari H; Shih TY; Kuzumaki N
    Exp Cell Res; 1993 Oct; 208(2):415-21. PubMed ID: 7690710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inhibition of ras-dependent transformation by using dominant negative ras mutant N116Y].
    Yokoyama T
    Hokkaido Igaku Zasshi; 1995 May; 70(3):459-71. PubMed ID: 7590597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of an ATP binding mutant of PKC-delta inhibits Sis-induced transformation of NIH3T3 cells.
    Li W; Michieli P; Alimandi M; Lorenzi MV; Wu Y; Wang LH; Heidaran MA; Pierce JH
    Oncogene; 1996 Aug; 13(4):731-7. PubMed ID: 8761294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Critical role of Rho in cell transformation by oncogenic Ras.
    Prendergast GC; Khosravi-Far R; Solski PA; Kurzawa H; Lebowitz PF; Der CJ
    Oncogene; 1995 Jun; 10(12):2289-96. PubMed ID: 7784077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
    Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
    Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant function of the Ras-related protein TC21/R-Ras2 triggers malignant transformation.
    Graham SM; Cox AD; Drivas G; Rush MG; D'Eustachio P; Der CJ
    Mol Cell Biol; 1994 Jun; 14(6):4108-15. PubMed ID: 8196649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. trans-Dominant suppressor mutations of the H-ras oncogene.
    Ogiso Y; Gutierrez L; Wrathall LS; Lu YY; Blair DG; Clanton DJ; Hwang YW; Shih TY
    Cell Growth Differ; 1990 May; 1(5):217-24. PubMed ID: 2150753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.